While, YY1 largely acted as a tumor promoter in prostate cancer, upon interacting with SFMBT2 (Scm-like with four mbt domains 2), YY1 acts both as a tumor promoter and suppressor in prostate cancer. Here, YY1 is linked to neoplasm.